Showing results (121-130 of 147) with videos related to
Sort By:
Pageof 15
Scientific Reports|August 5, 2020
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk scoreShun Kaneko, Masayuki Kurosaki, Kouji Joko, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 12, 2026
Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in JapanHironori Ochi, Masayuki Kurosaki, Takaaki Tanaka, et al.Cancer Research|April 1, 2022
Expansion of Gastric Intestinal Metaplasia with Copy Number Aberrations Contributes to Field CancerizationKen Kumagai, Takahiro Shimizu, Atsushi Takai, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 24, 2022
A validation study of after direct-acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct-acting antiviral therapy and achieved sustained virological responseToshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, et al.Journal of Gastroenterology and Hepatology|April 27, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated CirrhosisNobuharu Tamaki, Daniel Q Huang, Hyung Woong Lee, et al.Nature Communications|December 5, 2013
MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in miceTakahiro Horie, Tomohiro Nishino, Osamu Baba, et al.Cancer Immunology, Immunotherapy : CII|August 4, 2022
Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumabTatsuki Ikoma, Mototsugu Shimokawa, Toshihiko Matsumoto, et al.Hepatology (Baltimore, Md.)|January 12, 2023
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosisDaniel Q Huang, Nobuharu Tamaki, Hyung Woong Lee, et al.Hepatology Communications|October 22, 2021
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C VirusNobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.Journal of Medical Virology|June 25, 2021
Real-world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1- and 2-infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study GroupToshifumi Tada, Masayuki Kurosaki, Shinichiro Nakamura, et al.Pageof 15